AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gervais, D. A.
Right arrow Articles by Mueller, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gervais, D. A.
Right arrow Articles by Mueller, P. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2005; 185:64-71
© American Roentgen Ray Society


Original Research

Radiofrequency Ablation of Renal Cell Carcinoma: Part 1, Indications, Results, and Role in Patient Management over a 6-Year Period and Ablation of 100 Tumors

Debra A. Gervais1, Francis J. McGovern2, Ronald S. Arellano1, W. Scott McDougal2 and Peter R. Mueller1

1 Department of Radiology, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, MA 02114.
2 Department of Urology, Massachusetts General Hospital, Boston, MA 02114.

OBJECTIVE. The objectives of our article are to review our experience with radiofrequency ablation of renal cell carcinoma and to assess size and location as predictors of the ability to achieve complete necrosis by imaging criteria.

MATERIALS AND METHODS. Over a 6-year period, 100 renal tumors in 85 patients underwent radiofrequency ablation at a single institution. The absence of enhancement on CT or MRI after radiofrequency ablation was interpreted as complete coagulation necrosis. Results were analyzed by tumor size and location using multivariate analysis. A p value of 0.05 or less was considered significant.

RESULTS. All 52 small (3 cm) and all 68 exophytic tumors underwent complete necrosis regardless of size, although many large tumors (> 3 cm) required a second ablation session. Using multivariate analysis, we found that both small size (p < 0.0001) and noncentral location (p = 0.0049) proved to be independent predictors of complete necrosis after a single ablation session. Location was a significant predictor (p = 0.015) of complete necrosis after any number of sessions, whereas size showed a strong trend (p = 0.059) toward predicting success after any number of sessions. Complications were either self-limited or readily treated and included hemorrhage (major, n = 2; minor, n = 3), inflammatory track mass (n = 1), transient lumbar plexus pain (n = 2), ureteral injury (n = 2), and skin burns (n =1).

CONCLUSION. Radiofrequency ablation is a promising minimally invasive therapy for renal cell carcinoma in patients who are not good operative candidates. Small size and noncentral location are favorable tumor characteristics, although large tumors can sometimes be successfully treated with multiple ablation sessions.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
M. D. Michaelson, O. Iliopoulos, D. F. McDermott, F. J. McGovern, M. G. Harisinghani, and E. Oliva
Case 17-2008 -- A 63-Year-Old Man with Metastatic Renal-Cell Carcinoma
N. Engl. J. Med., May 29, 2008; 358(22): 2389 - 2396.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. P. Lokken, D. A. Gervais, R. S. Arellano, K. Tuncali, P. R. Morrison, S. Tatli, P. R. Mueller, and S. G. Silverman
Inflammatory Nodules Mimic Applicator Track Seeding After Percutaneous Ablation of Renal Tumors
Am. J. Roentgenol., October 1, 2007; 189(4): 845 - 848.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. J. Zagoria, M. A. Traver, D. M. Werle, M. Perini, S. Hayasaka, and P. E. Clark
Oncologic Efficacy of CT-Guided Percutaneous Radiofrequency Ablation of Renal Cell Carcinomas
Am. J. Roentgenol., August 1, 2007; 189(2): 429 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. F. Laeseke, T. M. Frey, C. L. Brace, L. A. Sampson, T. C. Winter III, J. R. Ketzler, and F. T. Lee Jr.
Multiple-Electrode Radiofrequency Ablation of Hepatic Malignancies: Initial Clinical Experience
Am. J. Roentgenol., June 1, 2007; 188(6): 1485 - 1494.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. E. Heilbrun, R. J. Zagoria, A. J. Garvin, M. C. Hall, K. Krehbiel, A. Southwick, and P. E. Clark
CT-Guided Biopsy for the Diagnosis of Renal Tumors Before Treatment with Percutaneous Ablation
Am. J. Roentgenol., June 1, 2007; 188(6): 1500 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. D. Atwell, M. A. Farrell, M. R. Callstrom, J. W. Charboneau, B. C. Leibovich, I. Frank, and D. E. Patterson
Percutaneous Cryoablation of Large Renal Masses: Technical Feasibility and Short-Term Outcome
Am. J. Roentgenol., May 1, 2007; 188(5): 1195 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
T. Sabharwal, N. Fotiadis, and A. Adam
Modern trends in interventional radiology
Br. Med. Bull., April 30, 2007; (2007) ldm006v1.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Mulier, Y. Ni, L. Frich, F. Burdio, A. L. Denys, J.-F. De Wispelaere, B. Dupas, N. Habib, M. Hoey, M. C. Jansen, et al.
Experimental and Clinical Radiofrequency Ablation: Proposal for Standardized Description of Coagulation Size and Geometry
Ann. Surg. Oncol., April 1, 2007; 14(4): 1381 - 1396.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
T. D. Atwell and M. A. Farrell
Invited Commentary
RadioGraphics, March 1, 2007; 27(2): 339 - 340.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
S. Kawamoto, S. Permpongkosol, D. A. Bluemke, E. K. Fishman, and S. B. Solomon
Sequential Changes after Radiofrequency Ablation and Cryoablation of Renal Neoplasms: Role of CT and MR Imaging
RadioGraphics, March 1, 2007; 27(2): 343 - 355.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Lam, A. Breda, A. S. Belldegrun, and R. A. Figlin
Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
J. Clin. Oncol., December 10, 2006; 24(35): 5565 - 5575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. J. Zagoria
"Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer"-- a commentary.
Am. J. Roentgenol., November 1, 2006; 187(5): 1149 - 1150.
[Full Text] [PDF]


Home page
NEJMHome page
W. S. McDougal, N. E. Tolkoff-Rubin, M. D. Michaelson, P. R. Mueller, and K. Braaten
Case 28-2006 -- A 59-Year-Old Man with Masses in Both Kidneys
N. Engl. J. Med., September 14, 2006; 355(11): 1161 - 1167.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
D. A. Gervais, R. S. Arellano, F. J. McGovern, W. S. McDougal, and P. R. Mueller
Radiofrequency Ablation of Renal Cell Carcinoma: Part 2, Lessons Learned with Ablation of 100 Tumors
Am. J. Roentgenol., July 1, 2005; 185(1): 72 - 80.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.